Fully disclosed PBM DisclosedRx operates as a fully disclosed PBM with 100% rebate and pricing pass-through and no revenue from other sources. This positions them as a transparent alternative to traditional PBMs, presenting a potential sales angle to mid-market health plans and self-insured employers seeking cost predictability and straightforward pricing.

Cost control focus The emphasis on enhanced specialty cost control programs and targeted pricing transparency suggests opportunities to upsell advanced cost containment services to clients managing high specialty drug spend, including self-insured employers and regional healthcare networks seeking lower net medication costs.

Partnership minded They describe themselves as the easiest PBM to partner with and showcase a partnership-first model. This creates a sales opening to collaborate with benefits brokers, employers, and health systems seeking a smooth onboarding and low-friction vendor relationship.

Strategic growth signals Recent partnership with Xevant indicates a push toward real-time analytics and data-driven decision-making for pharmacy benefits. This can be leveraged to offer joint analytics solutions, benchmarking, and performance-based pricing discussions with prospective clients.

Mid-market potential With 51-200 employees and revenue in a mid-range, DisclosedRx sits between smaller independents and larger PBMs. Target mid-market employers and regional health plans looking for transparent pricing and predictable costs, as well as self-insured organizations seeking a reputable, cost-focused PBM partner.